The North Carolina Agricultural and Technical State University?s Centre for Excellence in Post Harvest Technologies (CEPHT) is on a mission to defeat pathogens that cause foodborne illnesses and treat outbreaks more effectively.
The North Carolina Agricultural and Technical State University’s Centre for Excellence in Post Harvest Technologies (CEPHT) is on a mission to defeat pathogens that cause foodborne illnesses and treat outbreaks more effectively. CEPHT are one of eight universities, businesses and government organizations partnering at the North Carolina Research Campus (NCRS) to advance human health, nutrition and agriculture to prevent, treat and cure diseases.
According to The Centres for Disease Control and Prevention (CDC) the human and economic cost amounts to over 48 million foodborne illnesses, 128,000 hospitalizations and over 3000 deaths a year.
CEPHT’s interim director, lead scientist and associate professor of food microbiology and biotechnology, Leonard L. Williams, PhD, said, “Pathogens cause a lot of deaths, sickness and hospitalization, which results in a tremendous economic burden with loss of work and doctor visits, and on the food industry with recalls and lawsuits. Foodborne illness is probably one of the most costly to treat.”
The remedies that are being developed are natural alternatives to the synthetic options that are currently used. “Bacteria have the ability to acquire resistance and mutate consistently. With natural extracts, they have not quite figured out how to change their genetic material to become resistant,” Williams said. Alongside his co-investigators from Alabama A&M University, he has found that sorrel (Hibiscus sabdariffa) has antimicrobial activity that can inhibit E. coli O157:H7.
Williams is also leading a study to track, test and isolate specific pathogens on lettuce, green onions, sprouts and spinach in North Carolina, California, the US Midwest and Mexico.
For more information visit ref="http://www.ncresearchcampus.net">www.ncresearchcampus.net
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.